Loading the section
Company reports as filed with the U.S. Securities and Exchange Commission.
| Metric | 31 Mar 2026 | 30 Sept 2025 | 30 Jun 2025 | 31 Mar 2025 | 30 Sept 2024 | 30 Jun 2024 |
|---|---|---|---|---|---|---|
| Revenue | 851M | 793M | 773M | 746M | 725M | 708M |
| Cost of revenue | 142M | 133M | 138M | 137M | 126M | 128M |
| Research and development | 50M | 45M | 44M | 48M | 39M | 41M |
| Selling, general and administrative | 69M | 42M | 38M | 57M | 42M | 40M |
| Operating expenses | 394M | 346M | 347M | 369M | 323M | 325M |
| Operating income | 457M | 448M | 425M | 377M | 401M | 383M |
| Pre-tax income | 389M | 397M | 378M | 331M | 357M | 340M |
| Income tax | −17M | 71M | 74M | 42M | 76M | 73M |
| Net income | 406M | 325M | 304M | 289M | 281M | 267M |
| Earnings per share | 5.54 | 4.26 | 3.92 | 3.72 | 3.58 | 3.37 |
| Earnings per share, diluted | 5.53 | 4.25 | 3.92 | 3.71 | 3.57 | 3.37 |
| Weighted average shares | 73M | 76M | 77M | 78M | 78M | 79M |
| Weighted average shares, diluted | 73M | 77M | 77M | 78M | 79M | 79M |
| Metric | 31 Mar 2026 | 31 Dec 2025 | 30 Sept 2025 | 30 Jun 2025 | 31 Mar 2025 | 31 Dec 2024 | 30 Sept 2024 | 30 Jun 2024 |
|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | 385M | 515M | 400M | 347M | 361M | 409M | 501M | 451M |
| Receivables | 883M | 987M | 746M |
| Metric | 31 Mar 2026 | 30 Sept 2025 | 30 Jun 2025 | 31 Mar 2025 | 30 Sept 2024 | 30 Jun 2024 |
|---|---|---|---|---|---|---|
| Operating cash flow | 307M | — | — | 302M | — | — |
| Depreciation and amortisation | 6M | 6M | 5M | 5M |
Amounts in USD unless stated otherwise. Data: US exchange trading and company filings with the regulator
| 791M |
| 749M |
| 821M |
| 644M |
| 709M |
| Current assets | 1.39B | 1.64B | 1.31B | 1.27B | 1.24B | 1.34B | 1.29B | 1.32B |
| Property, plant and equipment | 87M | 87M | 83M | 86M | 86M | 71M | 62M | 64M |
| Goodwill | 2.96B | 2.92B | 2.92B | 2.93B | 2.92B | 2.92B | 2.92B | 2.91B |
| Total assets | 5.55B | 5.70B | 5.39B | 5.37B | 5.34B | 5.45B | 5.41B | 5.46B |
| Current liabilities | 1.61B | 1.83B | 1.48B | 1.47B | 1.47B | 1.59B | 1.38B | 1.38B |
| Short-term debt | — | — | — | — | — | 0 | 0 | 0 |
| Long-term debt | 6.40B | 6.20B | 5.51B | 4.51B | 4.55B | 4.51B | 4.48B | 4.51B |
| Total liabilities | 8.32B | 8.36B | 7.31B | 6.26B | 6.30B | 6.39B | 6.16B | 6.19B |
| Equity | −2.77B | −2.65B | −1.92B | −886M | −959M | −940M | −751M | −734M |
| Shares outstanding | 73M | 74M | 75M | 77M | 78M | 78M | 78M | 79M |
| Shares issued | 134M | 134M | 134M | 134M | 134M | 134M | 134M | 134M |
| Treasury shares | 62M | 61M | 59M | 57M | 57M | 56M | 56M | 55M |
| 4M |
| 4M |
| Share-based compensation | 48M | — | — | 40M | — | — |
| Capital expenditure | 3M | — | — | 12M | — | — |
| Investing cash flow | −71M | — | — | −33M | — | — |
| Dividends paid | 151M | — | — | 144M | — | — |
| Share buybacks | 415M | — | — | 213M | — | — |
| Financing cash flow | −365M | — | — | −322M | — | — |